The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVpc Specialty Regulatory News (VSL)

Share Price Information for Vpc Specialty (VSL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 49.00
Bid: 49.00
Ask: 50.80
Change: -1.00 (-2.00%)
Spread: 1.80 (3.673%)
Open: 50.40
High: 50.40
Low: 49.00
Prev. Close: 50.00
VSL Live PriceLast checked at -
VPC Specialty Lending Investments is an Investment Trust

To generate an attractive total return for shareholders consisting of dividend income and capital growth through investments in specialty lending opportunities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of circular relating to B share scheme

15 Mar 2024 07:00

RNS Number : 9472G
VPC Specialty Lending Invest. PLC
15 March 2024
 

THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND AND THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO MAY RESULT IN THE CONTRAVENTION OF ANY REGISTRATION OR OTHER LEGAL REQUIREMENT OF SUCH JURISDICTION

15 March 2024

VPC Specialty Lending Investments plc

Publication of a circular in relation to a B share scheme

The Board of VPC Specialty Lending Investments plc (the "Company") is pleased to announce details of the proposal to adopt a B Share Scheme to facilitate the return of capital to Shareholders as and when sufficient cash and reserves are available.

Background

In June 2023, Shareholders approved changes to the investment objective and policy of the Company. Pursuant to this change, the Company is managed with the objective of conducting an orderly realisation of the assets of the Company in a manner that seeks to achieve a balance between returning cash to Shareholders promptly and maximising value.

The Board has since then been reviewing potential mechanisms through which a proposed return of capital may be structured and has taken professional advice, including in relation to tax implications, and has reflected on views received from various Shareholders of the Company. 

B Share Scheme

After careful consideration, the Board has determined that the adoption of a B Share Scheme is one of the fairest and most efficient ways of returning capital to Shareholders. The B Share Scheme would allow the Company to return capital on a strict pro rata basis which would ensure as far as possible that no Shareholder or Shareholder group is disadvantaged. The adoption of the B Share Scheme would involve the Company issuing redeemable B Shares to Shareholders and redeeming them on the Redemption Date applicable to that issue of B Shares without further action being required by Shareholders.

The Board believes that returning capital via the B Share Scheme rather than via a tender offer, offers the following significant benefits to Shareholders:

· It reduces costs for the Company, as there should be no need to prepare further circulars to give effect to a future Return of Capital, which would not be the case with tender offers. Details of each Return of Capital notified to Shareholders will be by an announcement through the Regulatory Information Service and, subject to any change in existing United Kingdom tax law (and in contrast to a tender offer where stamp duty at the rate of 0.5 per cent. of the tender price is payable), no stamp duty would be payable by the Company.

· All Shareholders would participate in the redemption process and they would be treated equally. It is likely to be particularly beneficial for smaller retail Shareholders who may miss the opportunity to participate in a tender offer simply as a result of failing to make an election to participate.

· The proportionate holdings of Shareholders will remain unchanged as a result of the B Share Scheme.

· Subject to the Resolutions being passed at the General Meeting, Shareholders will not be required to take any further action to give effect to a future Return of Capital under the B Share Scheme.

· There would be greater certainty for the Company regarding the amount of capital that is able to be returned to Shareholders, given that unlike tender offers, capital returns under the B Share Scheme would be made to all Shareholders on a pro rata basis, without the need for an election.

Returns of Capital

The quantum and timing of a Return of Capital to Shareholders following receipt by the Company of the net proceeds of realisations of investments will be dependent on the repayment and cancellation of the Company's bank facilities, further drawdowns to honour commitments to fund under existing contractual arrangements, the Company's liabilities and general working capital requirements and sufficient distributable reserves and amounts standing to the credit of the Company's share premium account. Accordingly, the quantum and timing of any Return of Capital will be at the discretion of the Board, and details of each Return of Capital, including the relevant Record Date, Redemption Price and Redemption Date, will be notified to Shareholders by an announcement through the Regulatory Information Service. Subject to the passing of the Resolutions at the General meeting, the Board intends to announce the details of an initial Return of Capital under the B Share Scheme shortly after the General Meeting.

The adoption of a B Share Scheme will not limit the ability of the Company to return cash to Shareholders by using other mechanisms and, if the B Share Scheme is adopted, the Board will continue to review its efficacy over time. Details of the Board's intention to implement the B Share Scheme are set out in the Circular (as defined below).

The Board's proposal to adopt a B Share Scheme now should not be taken as any indication as to the likely timing or quantum of any future returns of cash to Shareholders.

General Meeting

The introduction of the B Share Scheme requires Shareholder approval, which will be sought at a General Meeting of the Company to held at the offices of Stephenson Harwood LLP, 1 Finsbury Circus, London EC2M 7SH on 5 April at 10.00 a.m. Resolution 1 is proposed as a special resolution and Resolutions 2 and 3, as ordinary resolutions. Together they seek approval for the B Share Scheme. A special resolution requires at least 75 per cent. of the vote cast to be in favour in order for the resolution to be passed. An ordinary resolution requires a majority of members entitled to vote and present in person or by proxy to vote in favour in order for it to be passed.

A circular containing further detail of the proposed adoption of a B Share Scheme to facilitate the return of capital to Shareholders and the notice convening the General Meeting has today been published by the Company (the "Circular").

A copy of the Circular will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. The Circular will also be available on the Company's website (https://vpcspecialtylending.com). Capitalised terms used in this announcement, unless otherwise defined, have the same meanings as set out in the Circular.

Enquiries:

VPC Specialty Lending Investments PLCGraeme Proudfoot

via Jefferies or Winterflood (below)

 

Victory Park CapitalGordon Watson

Sora Monachino

via Jefferies or Winterflood (below)

info@vpcspecialtylending.com

 

Jefferies International Limited

Stuart Klein

Gaudi le Roux

Tel: +44 20 7029 8000

 

Winterflood Securities Limited

Joe Winkley

Neil Morgan

Tel: +44 20 3100 0000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CIRSFMFWLELSEED
Date   Source Headline
24th Apr 20247:00 amRNSAnnual Financial Report
22nd Apr 20247:00 amRNSNet Asset Value(s)
17th Apr 20244:30 pmRNSInitial Return of Capital Exchange Ratio
9th Apr 20247:00 amRNSInitial Return of Capital through B Share Scheme
5th Apr 202411:23 amRNSResult of General Meeting
15th Mar 20247:00 amRNSPublication of circular relating to B share scheme
8th Mar 20243:00 pmRNSNet Asset Value(s)
22nd Feb 20248:54 amRNSReplacement - Dividend Declaration
22nd Feb 20247:00 amRNSDividend Declaration
7th Feb 20249:00 amRNSNet Asset Value(s)
17th Jan 20247:00 amRNSNet Asset Value(s)
8th Dec 20237:00 amRNSNet Asset Value(s)
17th Nov 20237:00 amRNSDividend Declaration
13th Nov 20237:00 amRNSNet Asset Value and Monthly Report
5th Oct 20237:00 amRNSNet Asset Value and Monthly Report
29th Sep 20237:00 amRNSHalf-year Report
6th Sep 20237:00 amRNSNet Asset Value and Monthly Report
24th Aug 20237:00 amRNSDividend Declaration
8th Aug 20231:21 pmRNSNet Asset Value and Monthly Report
13th Jul 202311:45 amRNSNet Asset Value(s) and Monthly Report
26th Jun 20237:00 amRNSDividend Declaration
23rd Jun 20235:08 pmRNSResult of AGM
12th Jun 20235:31 pmRNSResult of Meeting
7th Jun 20237:00 amRNSNet Asset Value(s)
31st May 20231:26 pmRNSDirectorate Change and Notice of AGM
16th May 20232:58 pmRNSCircular containing a Notice of General Meeting
11th May 202310:07 amRNSNet Asset Value(s)
28th Apr 20237:00 amRNSAnnual Financial Report
11th Apr 20235:33 pmRNSHolding(s) in Company
6th Apr 20237:00 amRNSNet Asset Value(s)
7th Mar 20237:00 amRNSNet Asset Value(s)
22nd Feb 20237:00 amRNSDividend Declaration
10th Feb 20237:00 amRNSNet Asset Value(s)
12th Jan 20237:00 amRNSNet Asset Value(s)
22nd Dec 20227:00 amRNSProposed Managed Wind-Down
8th Dec 20227:00 amRNSNet Asset Value(s)
7th Dec 20224:01 pmRNSReceipt of Requisition Notice
30th Nov 20227:00 amRNSDividend Declaration
8th Nov 20227:00 amRNSNet Asset Value(s)
11th Oct 202211:13 amRNSHolding(s) in Company
30th Sep 20227:00 amRNSNet Asset Value(s)
29th Sep 20227:00 amRNSHalf-year Report
31st Aug 20227:00 amRNSNet Asset Value(s)
25th Aug 20227:00 amRNSDividend Declaration
1st Aug 20227:00 amRNSNet Asset Value(s)
30th Jun 20227:00 amRNSNet Asset Value(s)
14th Jun 20227:00 amRNSDividend Declaration
13th Jun 20224:35 pmRNSResult of AGM
8th Jun 20227:00 amRNSNet Asset Value(s)
6th May 20225:54 pmRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.